Jorge Villacian
AuthID: R-00F-FP4
1
TITLE: Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial Full Text
AUTHORS: Pedro Cahn; Jorge Villacian; Adriano Lazzarin; Christine Katlama; Beatriz Grinsztejn; Keikawus Arasteh; Paulo Lopez; Nathan Clumeck; Jan Gerstoft; Nikolas Stavrianeas; Santiago Moreno; Francisco Antunes ; Dietmar Neubacher; Douglas Mayers;
PUBLISHED: 2006, SOURCE: CLINICAL INFECTIOUS DISEASES, VOLUME: 43, ISSUE: 10
AUTHORS: Pedro Cahn; Jorge Villacian; Adriano Lazzarin; Christine Katlama; Beatriz Grinsztejn; Keikawus Arasteh; Paulo Lopez; Nathan Clumeck; Jan Gerstoft; Nikolas Stavrianeas; Santiago Moreno; Francisco Antunes ; Dietmar Neubacher; Douglas Mayers;
PUBLISHED: 2006, SOURCE: CLINICAL INFECTIOUS DISEASES, VOLUME: 43, ISSUE: 10
